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Autosomal Dominant Rhegmatogenous Retinal
Detachment Associated with an Arg453Ter Mutation in
the COL2A1 Gene
Sioe Lie Go,1,2 Alessandra Maugeri,2 Jef J. S. Mulder,3 Marc A. van Driel,1,2
Frans P. M. Cremers,2 and Carel B. Hoyng1
PURPOSE. To investigate the clinical features and molecular
causes of autosomal dominant rhegmatogenous retinal detach-
ment (RRD) in two large families.
METHODS. Clinical examination and linkage analysis of both
families using markers flanking the COL2A1 gene associated
with Stickler syndrome type 1, the loci for Wagner disease/
erosive vitreoretinopathy (5q14.3), high myopia (18p11.31
and 12q21-q23), and nonsyndromic congenital retinal nonat-
tachment (10q21).
RESULTS. Fifteen individuals from family A and 12 individuals
from family B showed RRD or retinal tears with minimal (family
A) or no (family B) systemic characteristics of Stickler syn-
drome and no ocular features of Wagner disease or erosive
vitreoretinopathy. The RRD cosegregated fully with a chromo-
somal region harboring the COL2A1 gene with maximum lod
scores of 6.09 (family A) and 4.97 (family B). In family B, an
Arg453Ter mutation was identified in exon 30 of the COL2A1
gene, that was previously described in a patient with classic
Stickler syndrome. In family A, DNA sequence analysis revealed
no mutation in the coding region and at the splice sites of the
COL2A1 gene.
CONCLUSIONS. In two large families with RRD, linkage was found
at the COL2A1 locus. In one of these families an Arg453Ter
mutation was identified, which is surprising, because all pre-
dominantly ocular Stickler syndrome cases until now have
been associated with protein-truncating mutations in exon 2,
an exon subject to alternative splicing. In contrast, the
Arg453Ter mutation and other protein-truncating mutations in
the helical domain of COL2A1 have been associated until now
with classic Stickler syndrome. (Invest Ophthalmol Vis Sci.
2003;44:4035–4043) DOI:10.1167/iovs.02-0736
Rhegmatogenous retinal detachment (RRD) often is associ-ated with (pathologic) myopia and in most cases leads to
visual impairment or blindness if untreated.1,2 Early diagnosis
of RRD and recognition of patients at risk improve the prog-
nosis (see Ref. 3 and the references therein). Nonsyndromic
pathologic myopia (6 D or less) in most cases occurs sporad-
ically, but is also encountered as an autosomal dominant or
X-linked trait in families.4–7 RRD with autosomal dominant
inheritance in association with myopia and vitreoretinal degen-
eration is usually described as a feature of Stickler syndrome or
erosive vitreoretinopathy. RRD also has been reported in the
original Wagner family, although less frequent.8
Stickler syndrome is characterized by such systemic abnor-
malities as midfacial hypoplasia, midline cleft of the palate,
sensorineural hearing loss, early progressive arthropathies, and
hypermobility, in combination with ocular abnormalities, such
as high myopia, abnormalities of the vitreous structure, para-
vascular pigmentation, and possibly giant tears causing retinal
detachment.9–11 Mitral valve prolapse also has been report-
ed.12 These features show intra- and interfamilial variability of
expression. Moreover, different types of Stickler syndrome can
be distinguished based on the presence or absence of ocular
abnormalities, the appearance of the vitreous, and the molec-
ular genetic findings. Type 1 Stickler syndrome is characterized
by a membranous vitreous phenotype and is caused by muta-
tions in the COL2A1 gene.13–15 Type 2 Stickler syndrome
exhibits a different beaded vitreous phenotype and has been
associated with COL11A1 mutations.15–17 Nonocular Stickler
syndrome type 3, with a phenotype displaying characteristic
systemic abnormalities such as facial abnormalities, cleft pal-
ate, hearing loss, and arthropathies, but without high myopia,
vitreoretinal degeneration, or retinal detachments, is caused by
mutations in COL11A2.18–20 Evidence of at least a fourth locus
for Stickler syndrome has been found, as mutations in the
former three known genes were not found in some Stickler
families.17,21
Wagner disease, on the other hand, is a nonsystemic disor-
der in which the vitreous is optically empty, and a preretinal
membrane is present in the periphery of the retina, sometimes
only as a thin white circular line. A progressive complicated
cataract appears in most of the patients, chorioretinal atrophy,
peripheral pigment foci, and a situs inversus of the optic disc
may be present.22–24 Wagner disease has been mapped to the
long arm of chromosome 5 in region 14.3 (5q14.3).25
In erosive vitreoretinopathy, progressive thinning of the
retinal pigment epithelium resulting in severe degeneration is
the major feature. In addition, and in contrast with Wagner
disease, a pronounced roped and veiled syneresis of the vitre-
ous body with traction at lesions of the retinal pigment epithe-
lium and frequent development of retinal detachment, both
rhegmatogenous and tractional, are observed. As in Wagner
disease, no systemic abnormalities are found.26,27 The disorder
maps to the same region as Wagner disease, 5q13-q14,27 sug-
gesting that erosive vitreoretinopathy and Wagner disease may
be allelic disorders.
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FIGURE 1. Haplotype analysis of families with RRD or retinal breaks with markers encompassing the COL2A1 gene on the long arm of chromosome
12, region 13.11. The COL2A1 gene resides between markers D12S1701 and D12S1661. The shared alleles from the at-risk haplotype are shown
in black bars, marker alleles between brackets are deduced. (A) Family A: the boundaries of the critical interval between D12S1631 and D12S1691
are determined by recombination events in affected individuals AIII-8, AIII-16, and AIV-2. (B) Family B: the critical interval between D12S1663 and
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In this report, we present two large families with auto-
somal dominant RRD or retinal breaks without or with mini-
mal systemic features, clinically different from Wagner disease,
erosive vitreoretinopathy, and typical Stickler syndrome. Both
families showed linkage to a genomic region containing
the COL2A1 gene. In one of the families, a stop codon muta-
tion was found in the helical domain of the COL2A1 gene that
had been found earlier in a patient with typical Stickler syn-
drome.
PATIENTS AND METHODS
Two unrelated Dutch families of white origin with autosomal dominant
RRD were studied. Family A consisted of 28 individuals; family B
consisted of 22 (Fig. 1). The study protocol followed the tenets of the
Declaration of Helsinki, and informed consent was obtained from each
participant or their guardians, after general approval by the Ethics
Committee of the University Medical Centre Nijmegen, The Nether-
lands.
Clinical Examination
An extensive clinical history of all individuals especially regarding
ophthalmic, audiologic, cardiologic, and orthopedic disorders, and
current symptoms was recorded. Existing ophthalmic records of all
participants and, if possible, of the deceased were collected and re-
viewed regarding age of onset of myopia, structure of the vitreous
body, retinal breaks, retinal detachments or other abnormalities of the
fundus, biometric measurements, and intraocular pressure. Clinical
examination included best corrected visual acuity, slit lamp micros-
copy, applanation tonography, fundoscopy including fundus photog-
raphy, and Goldmann three-mirror contact glass examination. These
examinations were performed in 27 individuals in family A and 22
individuals in family B by both a highly experienced medical retina
specialist (CBH) and by the first author (SLG). Special attention was
paid to the vitreous body structure. Axial length measurement and
keratometry were performed, using ultrasound. In cases of axial length
of 25 mm or longer or in cases with closed pupillae, ultrasound
examination of the posterior eye was performed. All individuals with
retinal detachments or retinal breaks were considered affected.
Physical examination including assessment of facial, palatal, joint,
and heartsound abnormalities was prospectively performed in affected
individuals who were willing to cooperate. Existing audiologic, cardi-
ologic, and orthopedic medical records were collected. Facial and
palatal photographs were taken. The Beighton score for hypermobility
of joints28 and audiometry were assessed in six members of family A
and 10 of family B.
Molecular Genetic Analysis
DNA was extracted from leukocytes from 10 mL of peripheral blood of
all individuals, according to a protocol adapted from Miller et al.29
Linkage analysis was performed with radioactively labeled microsatel-
lite markers. The candidate loci were the two loci for autosomal
dominant high myopia on 18p11.31 (MYP2; markers D18S52
[AFM020tf12] and D18S1154 [AFMa056ye1]) and 12q21-q23 (MYP3;
markers D12S64 [MFd155a], D12S82 [AFM107xc11] and D12S317
[AFM065ye9]), the Wagner disease/erosive vitreoretinopathy locus on
5q14.3 (markers D5S428 [AFM238xf4] and D5S2094 [AFMa055td9]),
the locus for nonsyndromic congenital retinal nonattachment on
10q21 (marker D10S581 [AFM287yf9]), and the genes for Stickler
syndrome COL2A1 on 12q13.11-13.2 and COL11A1 on 1p21.1. For
COL2A1, residing between markers D12S1701 and D12S1661, we
used the following markers (from pter to qter; genetic distances indi-
cated): D12S1631 (AFMa288wd5) - 5.8 centimorgans (cM) - D12S1663
(AFMb316xd9) - 6.2 cM - D12S1701 (AFM345xf1) - 1.4 cM - D12S1661
(AFMb314yh5) - 4.6 cM - D12S1618 (AFMa224yg1) - 3.6 cM - D12S1691
(AFM312xf5) - 5.3 cM - D12S335 (AFM273vg9).30 No marker near
COL11A1 was tested, because linkage was found at the COL2A1 locus.
DNA samples were subjected to polymerase chain reaction (PCR)
amplification with a standard cycling profile of 30 cycles at 94°C, 55°C
and 72°C for 1, 2, and 1 minute(s), respectively, at each step. DNA
markers were labeled by the incorporation of [32P]-dCTP, and the
products were separated by electrophoresis on a 6.6% denaturing
polyacrylamide gel.
Linkage analysis by calculating two-point lod scores was performed
using the MLINK routine from LINKAGE (ver. 5.1) software suite
(http:www.hgmp.mrc.ac.uk/; provided in the public domain by the
Human Genome Mapping Project Resources Center, Cambridge,
UK).31–33 Lod scores in both families were calculated with a presumed
penetrance rate of 95% and an allele frequency of 0.001.
Mutation analysis of the COL2A1 gene was performed by direct
sequencing (BigDye Terminator on a Prism 377; Applied Biosystems,
Foster City, CA). The entire coding region of the gene, comprising 54
exons, was amplified in 38 amplicons. Primer pairs and conditions are
available on request. To ascertain mutations that could affect the
splicing, at least 42 bp (average 104 bps) of the flanking intronic
sequences were amplified. Twenty-one introns (introns 3–6, 9, 13, 20,
21, 24, 25, 30, 32, 35, 40, and 42–48) were entirely amplified. Se-
quence analysis was performed on both strands of each amplicon using
both forward and reverse primers.
To assess the stability of the mutant COL2A1 messenger RNA
(mRNA), Epstein-Barr virus–transformed lymphoblastoid cell lines
were established from heparin blood of two affected individuals from
family B. Before RNA extraction, half of the cultured cells were incu-
bated for 4 hours with 100 g/mL cycloheximide. In cells grown with
cycloheximide, a protein synthesis inhibitor, the nonsense-mediated
mRNA decay process is prevented.34 After RNA extraction and reverse
transcription-PCR (RT-PCR), a fragment of the cDNA encompassing the
mutation in exon 30 was amplified using a first set of primers, 5051F
(5-tgcctggtgaaagaggacggac-3) and 5054R (5-ggcattccctgaagacctggag-
3), followed by a nested PCR and direct sequencing of the band of
interest with primer 5053F (5-tcaagatggtctggcaggtccc-3) and the
same reverse primer 5054R.
RESULTS
Clinical Examination
The ophthalmic examination was performed in 27 of 28 indi-
viduals from family A and in all 22 individuals from family B.
One individual (AIII-3) refused prospective clinical examina-
tion, but could be considered affected because a retinal break
was described in his medical files. Medical files of AI-2 and AII-1
were not available, but these family members were determined
by hearsay to be affected. The medical files of individual BI-1
showed a retinal break and that person was thus considered to
be affected. BI-2 had no known health problems before her
death. The clinical features of all affected individuals (15/28 in
family A, 12/22 in family B) and the available information about
BI-1 are shown in Table 1. Refractive error comprised the
whole scale of mild hypermetropia to high myopia in family A,
whereas the scale was limited between no myopia and severe
Š
D12S335 is determined by recombination events in affected individuals BII-15 and BIII-5. Note that marker D12S1691 in individuals BII-2 and BIII-4
are noninformative or not known (gray bars). Assuming that individual BIII-6 is not a nonpenetrant, the telomeric boundary is demarcated by
marker D12S1691, thereby reducing the critical region to 15.8 cM. The DNA marker order and distances were derived from the Human Genome
Browser (April 2002 assembly)46 and Ge´ne´thon (www.genethon.fr; provided in the public domain by the French Association against Myopathies,
Evry, France).30 Note the overlap of the critical intervals of families A and B.
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myopia in family B, with a tendency toward moderate or high
myopia. In both families, the myopia was axial-length depen-
dent (mean axial lengths: 24.8 mm [range, 20.2–28.2 mm] in
family A; 26.6 mm [range, 24.9–28.7 mm] in family B). There
was no specific abnormality of the vitreous body that was
found in all affected individuals in both families, especially no
consistent vitreal membranes or beaded strands. Only RRDs, or
at least retinal breaks, were a consistent ophthalmic finding
throughout the families. In family A, 11 RRDs occurred in 8 of
the 15 affected family members, with an average age of first
onset of RRD of 36 years (range, 16–64 years). Seven of the 12
affected members of family B experienced early RRDs in nine
eyes. The average age of onset of RRD in this family was 14
years (range, 7–22 years). Eyes with RRDs showed a tendency
to multiple (average, 2; range, 0–7) peripheral holes or horse-
shoe tears in the temporal superior and inferior quadrants in
family A, whereas the periphery of the eyes of the affected in
family B mostly revealed round multiple (average, 8; range,
1–28) retinal holes in the temporal superior quadrant. Bilateral
RRDs were seen in patients AIII-5, AIII-18, AIV-2, BII-2, and
BIII-4.
The history and clinical examination of all examined indi-
viduals of both families revealed no systemic abnormalities,
except for five persons. Individual AII-6 had a history of surgery
for a left-side cerebellar cyst and showed a sensorineural hear-
ing defect in all frequencies of the left ear only. Thresholds at
frequencies 0.25, 0.5, 1, 2, 4, and 8 kHz (thresholds more than
age-related hearing loss between brackets), respectively, were
[50], 20, [50], [70], [100], and [110] dB hearing loss at the age
of 76 years. AIII-2, at 54 years of age, had a slightly recessed
chin, a symptomatic progressive low- and midfrequency sen-
sorineural hearing loss with thresholds of [25], [42.5], [55],
[50], 32.5, and 40 dB, respectively, for both ears (ADS), and
symptoms of occasionally stiff fingers of both hands and pains
in her left knee after long walks. AIII-5 had thresholds of 15,
17.5, [25], [30], 30, and [67.5] dB hearing loss ADS, but was
asymptomatic at 53 years. AIII-6 had a noise-exposition history
and at the age of 51 years showed thresholds of 12.5, 17.5, 5,
7.5, [50], and 7.5 dB hearing loss ADS. Finally, individual BIII-4
had a transient flat nose bridge in the first decade of his life, but
now has a normal facial appearance. Individuals BII-15 and
BIII-3 showed a small air bone gap of 7 dB, probably related to
tubal dysfunction at the time. As was true of all other patients
from this family, they had a normal symmetrical age-related
sensorineural threshold.
DNA Analysis
We excluded the involvement of the MYP2 and MYP3 loci for
autosomal dominant high myopia, as well as the loci for Wag-
ner disease/erosive vitreoretinopathy and nonsyndromic con-
genital retinal nonattachment by linkage analysis in family A
(Table 2).
In both families, highly polymorphic DNA markers flanking
the COL2A1 gene showed cosegregation with the disease (Ta-
ble 2). In family A, the critical region is demarcated by markers
D12S1631 and D12S1691 (interval: 21.6 cM, 28 Mb), based on
crossovers observed in the affected individuals AIII-8, AIII-16,
and AIV-2 (Fig. 1A). The maximum lod score, 6.09, was de-
tected for marker D12S1661 at a recombination fraction () of
0.0. In family B, a linked chromosomal region of 21.1 cM (26
Mb) was delimited by markers D12S1663 and D12S335, based
on recombination events observed in affected individuals
BII-15 and BIII-5 (Fig. 1B). A maximum lod score of 4.97 was
found for marker D12S1618 at   0.0. Assuming that the
healthy individual BIII-6 is not a nonpenetrant, the telomeric
boundary is demarcated by marker D12S1691, thereby reduc-
ing the critical region to 15.8 cM (16 Mb). In family A, analysis
of all 54 exons and flanking intronic regions of COL2A1 failed
to identify a mutation in the coding region or at the splicing
sites of the gene.
In family B, mutation analysis of the COL2A1 gene showed
a C-to-T transition in exon 30 (previously denoted as exon 28),
resulting in a change of codon CGA of Arg453 for a stop codon
(Fig. 2A). Ninety-six ethnically matched controls did not show
this mutation. Analysis of RNA extracted from lymphoblastoid
cells grown with and without cycloheximide from patient BII-6
showed stability of mutant RNA only in cells grown with
cycloheximide (Fig. 2B), strongly suggesting that the COL2A1
mRNA carrying the Arg453Ter mutation is unstable.
TABLE 2. Lod Scores for Two-Point Linkage Analysis in RRD Families A and B
Locus Location Marker
Recombination Fraction
0.000 0.010 0.050 0.100 0.200 0.300 0.400 0.500
Family A
MYP2 18p11.31 D18S52 11.13 6.00 3.16 1.85 0.69 0.22 0.04 0.00
D18S1154 12.01 7.29 3.71 2.03 0.60 0.07 0.07 0.00
MYP3 12q21–q23 D12S64 4.04 1.17 0.11 0.35 0.56 0.40 0.14 0.00
D12S82  10.43 6.67 4.54 2.16 0.93 0.29 0.00
D12S317 8.31 4.88 3.01 1.78 0.62 0.17 0.03 0.00
WGNI/ERVR 5q14.3 D5S428 9.18 5.21 2.54 1.32 0.30 0.02 0.07 0.00
D5S2094 8.31 4.33 2.42 1.49 0.63 0.24 0.05 0.00
NCRNA 10q21 D10S581 0.86 0.84 0.74 0.63 0.40 0.20 0.05 0.00
COL2A1 12q13.11–q13.2 D12S1631 5.38 2.00 3.01 3.10 2.63 1.82 0.84 0.00
D12S1663 4.91 4.82 4.45 3.97 2.97 1.91 0.82 0.00
D12S1701 5.79 5.69 5.28 4.75 3.63 2.41 1.11 0.00
D12S1661 6.09 5.98 5.56 5.01 3.83 2.56 1.19 0.00
D12S1618 5.79 5.69 5.28 4.75 3.63 2.42 1.11 0.00
D12S1691 0.81 1.55 2.30 2.46 2.17 1.53 0.69 0.00
Family B
COL2A1 12q13.11–q13.2 D12S1631 3.23 1.67 2.28 2.37 2.03 1.39 0.54 0.00
D12S1663 1.93 2.89 3.27 3.16 2.56 1.72 0.69 0.00
D12S1701 2.62 2.58 2.38 2.13 1.59 0.99 0.37 0.00
D12S1661 1.72 1.69 1.57 1.41 1.07 0.68 0.26 0.00
D12S1618 4.97 4.89 4.55 4.12 3.17 2.09 0.86 0.00
D12S1691 0.42 0.47 0.58 0.62 0.54 0.35 0.11 0.00
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DISCUSSION
In this study, we report on a family (B) with autosomal domi-
nant RRD associated with a mutation in the triple helical
domain of the COL2A1 gene. The mutation, Arg453Ter, has
been described in a sporadic patient with Stickler syndrome,
who had had such classic features as cleft palate, midfacial
hypoplasia, sensorineural hearing loss, joint laxity, and joint
pains since the second decade, besides high myopia, vitreoreti-
nal degeneration with a typical type I vitreous anomaly (Wil-
liam G. Cole, personal communication, 2002), retinal breaks,
and retinal detachment in the first decade.35 Protein truncating
COL2A1 mutations are commonly found in patients with Stick-
ler syndrome.
The phenotype observed in patients in family B however,
was different from the classic Stickler syndrome. In all 12 RRD
patients—even in the eldest generation—cleft palate, joint
laxity, joint pains or sensorineural hearing loss were absent,
whereas these symptoms were already present in the reported
23-year-old patient.35
Use of Snead’s criteria—that is, a congenital vitreous anom-
aly (type 1: membranous, or type 2: fibrillar, beaded) and any
three of the following: (1) myopia with onset before 6 years of
age, (2) RRD or paravascular pigmented lattice degeneration,
(3) joint hypermobility with abnormal Beighton score, either
with or without radiologic evidence of joint degeneration, (4)
audiometric confirmation of sensorineural hearing defect, and
(5) midline clefts15 in this family also indicates that the patients
in family B are clinically different from patients with classic
Stickler syndrome. First of all, excepting four patients in whom
membranelike vitreous abnormalities were found (individuals
BII-4, BII-12, BIII-3 and BIII-4), no members of family B revealed
a vitreous consistent with a type I or type II Stickler vitreous.
In BII-4, the membranelike structure was absent 23 years later,
possibly due to degeneration of the membrane.
Furthermore, myopia, if present, was not always present
before 6 years of age (data not shown). Joint hypermobility
with abnormal Beighton score and midline clefts were not
observed, and were not anamnestically present during child-
hood. Audiometric results were not suggestive of Stickler syn-
drome, and in both BIII-3 and BII-15 were most probably due to
tubal dysfunction at the time of examination. Moreover, al-
though none of the affected individuals from family B had joint
pains, according to surveys, 70% of patients with Stickler syn-
drome have joint pains before 20 years of age.36
Family A, in which the underlying genetic defect also co-
segregated with the COL2A1 locus, although no mutation
could be detected in the coding region and at the splice sites
of the gene, also does not meet the classic criteria nor Snead’s
criteria for Stickler syndrome. First, the vitreous of all family
members does not comprise consistent membrane- or thread-
like abnormalities, though a thin vitreous body was present in
several family members. In addition, a whole range of refrac-
tive errors between mild hypermetropia and high myopia was
found in all affected individuals. No cleft palates were found,
and though sensorineural hearing loss was found in four indi-
FIGURE 2. COL2A1 mutation analy-
sis in patient BII-6. (A) DNA se-
quence analysis of part of exon 30
(previously denoted as exon 28) of
the COL2A1 gene. Top: sequence of
a control individual; bottom: se-
quence of the clinically affected indi-
vidual BII-6, carrying a heterozygous
C-to-T transition resulting in an
Arg453Ter mutation. (B) RNA analy-
sis of the Arg453Ter mutation in pa-
tient BII-6. Top: sequence of the
cDNA of the patient. Because of
mRNA instability, the transcript of
the mutant allele was not detectable.
Bottom: sequence of the patient’s
cDNA obtained after incubation of
lymphoblastoid cells in a medium
containing cycloheximide, which
prevents nonsense-mediated mRNA
decay. Sequence analysis shows pres-
ence of transcripts from both the
normal and the mutant allele.
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viduals, it was not typical of Stickler syndrome. Two of these
hearing defects are explained by noise exposition (AIII-6) and
a left-side cerebellar cyst that had been surgically removed
(AII-6). AIII-5 had an asymptomatic mid- and high-frequency
hearing loss of 10 dB more than age-related hearing loss and
only one individual, AIII-2, had a symptomatic, progressive
sensorineural hearing defect of 23 dB more than age-related
hearing loss. However, the defect in this patient affected the
low- and midfrequencies, although in patients with Stickler
syndrome, the hearing impairment generally involves the high
frequencies and shows no more progression than is associated
with normal aging.11,37 Joint hypermobility was not present
during childhood and was not observed in those who had been
examined. Except in patient AIII-2 at 51 years of age and
patient AIII-5 who had pains in the left hip region during
unexpected hip movements at age 49 years, no joint pains
were found in patients in family A. Radiography of patient
AIII-5 showed a moderate arthrosis of and reduced joint space
in her left hip at the age of 52 years.
Previously described families with predominantly ocular
Stickler syndrome invariably showed a type I vitreous anomaly,
and all had mild to moderate systemic abnormalities, be it that
these were present in only approximately half of the examined
family members.38 Also, if we consider each of these families as
one unit, the abnormalities found in one family altogether
invariably led to a complete Stickler syndrome diagnosis by
Snead’s criteria. This family diagnosis could not be made in
each of our families, when taking into account all clinical
abnormalities. There also was no consistent type I vitreous
anomaly.
We think that patients in families A and B did not have
Wagner disease, because strongly progressive juvenile cataract
and inverted papilla, preretinal membranes or peripheral cir-
cular lines were not present. Moreover, of the 15 affected
members of family A, only 4 showed an optically empty vitre-
ous body and 1 had empty spaces in the vitreous body,
whereas in family B only 1 of 12 affected individuals showed an
optically empty vitreous body. In contrast, this was invariably
present in patients from the original Wagner family.22
In conclusion, our results suggest that the patients in fam-
ilies A and B had an atypical form of predominantly ocular
Stickler syndrome with RRD as the main clinical feature. An
important difference between both families is that retinal
breaks and detachments in family B occurred at younger ages,
mostly in the second and third decades, whereas in family A
they mostly appeared in the fourth and fifth decades and, in a
few cases, even later (individuals AII-4, AII-6, AII-7, and AIII-6;
Table 1).
Until recently, it seemed that COL2A1 gene mutations could
be associated with type 1 vitreous, whereas COL11A1 gene
mutations were responsible for type 2 vitreous. Discussion of
the role of the vitreous types in predicting the mutated gene,
however, was recently published.39,40 In fact, a Stickler family
with a type I vitreous had linkage to COL11A1,39 whereas in
two Stickler families with a type II vitreous, COL11A1 gene
mutations were excluded.21 Earlier posterior vitreoretinal de-
tachment was suggested to have caused these phenotypes,
because in two families conversion from vitreous phenotype 2
into 1 was observed.40 Our data also contradict the hypothesis
that all COL2A1 mutations are associated with a type I vitreous.
The most interesting result of this study, however, is the
identification of a COL2A1 exon-30 protein-truncating muta-
tion (Arg453Ter), previously identified in a patient with classic
Stickler syndrome,35 in a large family with an atypical form of
predominantly ocular Stickler syndrome.
Collagen molecules are typically composed of three
polypeptide chains (-chains) that form a triple helix. A char-
acteristic repetitive amino acid sequence, glycine-X-Y, is im-
portant for maintaining this helical structure. Three identical
1(II) chains, encoded by the COL2A1 gene, constitute colla-
gen II, the main collagen in cartilage and vitreous. Moreover,
1(II) chains participate in the formation of collagen V/XI in
combination with 1(XI) and 2(XI) chains in the cartilage,
and 1(XI) and 2(V) chains in the vitreous.41
The COL2A1 gene is involved in several autosomal domi-
nant disorders.42 A variety of cartilage disorders, such as achon-
drogenesis, spondyloepiphyseal dysplasia, and Kniest dyspla-
sia, are caused by missense mutations in COL2A1, generally
changing one of the glycine residues of the triple helical struc-
ture, or by small in-frame deletions.42 All these mutations
probably disrupt normal collagen II and collagen V/XI struc-
ture through a dominant negative mechanism.
On the contrary, all COL2A1 mutations described in pa-
tients with Stickler syndrome (Refs. 34, 35 and references
therein) with a few exceptions43,44 lead to a premature termi-
nation codon. Some authors demonstrated that mutant mRNAs
in patients with Stickler syndrome undergo nonsense-mediated
mRNA decay, resulting in COL2A1 haploinsufficiency.44,45
Haploinsufficiency of 1(II) chain molecules could affect col-
lagen II production or, more likely, disturbs the stochiometry
of V/XI collagen.
The discovery of premature termination mutations in exon
2 of the COL2A1 gene in all families with predominantly ocular
Stickler syndrome38 led to the speculation that exon 2 null
mutations merely give rise to ocular abnormalities, because
exon 2 is subject to alternative splicing and is predominantly
present in fetal and adult vitreous mRNA, but is absent in
mature cartilage mRNA. However, this explanation cannot
apply to our families. In fact, no mutations were found in exon
2 of the COL2A1 gene in either family, whereas the Arg453Ter
mutation in family B was located in the COL2A1 helical domain
of the gene.
RNA analysis in a patient in family B suggests that, as in
typical Stickler syndrome,44,45 haploinsufficiency underlies the
disease. Although clinical variability in Stickler syndrome is
very high, it does not satisfactorily account for the absence of
systemic features in as large a family as family B.
As clinical variability in Stickler syndrome can generically be
attributed to modifier factors, an intriguing hypothesis in our
case would be that a transacting modifier factor is located in
the vicinity of the COL2A1 locus, and that a favorable modifier
allele cosegregates in family B with the Arg453Ter COL2A1
mutation, resulting in the relatively mild phenotype. However,
it is worthwhile to note that family B belongs to a relatively
closed religious community. It is therefore possible that, more
broadly, individuals of this family share a common “favorable”
genetic background, due to one or more traits, that can reside
everywhere in the genome.
In family A, no COL2A1 mutation was found in the coding
sequence, at the splice sites or in the 21 introns of the gene
that have been entirely sequenced. Whether the disease in
family A follows a mechanism similar to that in family B re-
mains to be elucidated.
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